These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 26322632)

  • 1. Neurophysiological Evidence of Compensatory Brain Mechanisms in Early-Stage Multiple Sclerosis.
    López-Góngora M; Escartín A; Martínez-Horta S; Fernández-Bobadilla R; Querol L; Romero S; Mañanas MÀ; Riba J
    PLoS One; 2015; 10(8):e0136786. PubMed ID: 26322632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive event-related potentials in multiple sclerosis: Correlation with MRI and neuropsychological findings.
    Kimiskidis VK; Papaliagkas V; Sotirakoglou K; Kouvatsou ZK; Kapina VK; Papadaki E; Tsimourtou V; Masoura E; Kazis DA; Papayiannopoulos S; Geroukis T; Bostanjopoulou S
    Mult Scler Relat Disord; 2016 Nov; 10():192-197. PubMed ID: 27919489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological (EEG) evidence for reduced performance monitoring in euthymic bipolar disorder.
    Morsel AM; Morrens M; Temmerman A; Sabbe B; de Bruijn ER
    Bipolar Disord; 2014 Dec; 16(8):820-9. PubMed ID: 25219677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of performance monitoring abilities following traumatic brain injury: the influence of negative affect and cognitive sequelae.
    Larson MJ; Fair JE; Farrer TJ; Perlstein WM
    Int J Psychophysiol; 2011 Oct; 82(1):61-8. PubMed ID: 21315777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overactive performance monitoring in obsessive-compulsive disorder: ERP evidence from correct and erroneous reactions.
    Endrass T; Klawohn J; Schuster F; Kathmann N
    Neuropsychologia; 2008; 46(7):1877-87. PubMed ID: 18514679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished error-related brain activity as a promising endophenotype for substance-use disorders: evidence from high-risk offspring.
    Euser AS; Evans BE; Greaves-Lord K; Huizink AC; Franken IH
    Addict Biol; 2013 Nov; 18(6):970-84. PubMed ID: 23145495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
    Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in PASAT performance correlates with change in P3 ERP amplitude over a 12-month period in multiple sclerosis patients.
    Kiiski H; Reilly RB; Lonergan R; Kelly S; O'Brien M; Kinsella K; Bramham J; Burke T; O'Donnchadha S; Nolan H; Hutchinson M; Tubridy N; Whelan R
    J Neurol Sci; 2011 Jun; 305(1-2):45-52. PubMed ID: 21457995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct mechanisms of altered brain activation in patients with multiple sclerosis.
    Morgen K; Sammer G; Courtney SM; Wolters T; Melchior H; Blecker CR; Oschmann P; Kaps M; Vaitl D
    Neuroimage; 2007 Sep; 37(3):937-46. PubMed ID: 17627848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compromised motor imagery ability in individuals with multiple sclerosis and mild physical disability: an ERP study.
    Tabrizi YM; Mazhari S; Nazari MA; Zangiabadi N; Sheibani V; Azarang S
    Clin Neurol Neurosurg; 2013 Sep; 115(9):1738-44. PubMed ID: 23639730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prefrontal neuromodulation using rTMS improves error monitoring and correction function in autism.
    Sokhadze EM; Baruth JM; Sears L; Sokhadze GE; El-Baz AS; Casanova MF
    Appl Psychophysiol Biofeedback; 2012 Jun; 37(2):91-102. PubMed ID: 22311204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine Learning EEG to Predict Cognitive Functioning and Processing Speed Over a 2-Year Period in Multiple Sclerosis Patients and Controls.
    Kiiski H; Jollans L; Donnchadha SÓ; Nolan H; Lonergan R; Kelly S; O'Brien MC; Kinsella K; Bramham J; Burke T; Hutchinson M; Tubridy N; Reilly RB; Whelan R
    Brain Topogr; 2018 May; 31(3):346-363. PubMed ID: 29380079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preserved performance monitoring and error detection in left hemisphere stroke.
    Niessen E; Ant JM; Bode S; Saliger J; Karbe H; Fink GR; Stahl J; Weiss PH
    Neuroimage Clin; 2020; 27():102307. PubMed ID: 32570207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contribution of cognitive evoked potentials for detecting early cognitive disorders in multiple sclerosis].
    Magnié MN; Bensa C; Laloux L; Bertogliati C; Faure S; Lebrun C
    Rev Neurol (Paris); 2007 Nov; 163(11):1065-74. PubMed ID: 18033045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unavoidable errors: a spatio-temporal analysis of time-course and neural sources of evoked potentials associated with error processing in a speeded task.
    Vocat R; Pourtois G; Vuilleumier P
    Neuropsychologia; 2008 Aug; 46(10):2545-55. PubMed ID: 18533202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A neurophysiological study of the detrimental effects of alprazolam on human action monitoring.
    Riba J; Rodríguez-Fornells A; Münte TF; Barbanoj MJ
    Brain Res Cogn Brain Res; 2005 Oct; 25(2):554-65. PubMed ID: 16168630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reorganization in cognitive networks with progression of multiple sclerosis: insights from fMRI.
    Loitfelder M; Fazekas F; Petrovic K; Fuchs S; Ropele S; Wallner-Blazek M; Jehna M; Aspeck E; Khalil M; Schmidt R; Neuper C; Enzinger C
    Neurology; 2011 Feb; 76(6):526-33. PubMed ID: 21300967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. fMRI investigation of disinhibition in cognitively impaired patients with multiple sclerosis.
    Smith AM; Walker LA; Freedman MS; DeMeulemeester C; Hogan MJ; Cameron I
    J Neurol Sci; 2009 Jun; 281(1-2):58-63. PubMed ID: 19344919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of cognitive fatigue in Multiple Sclerosis with novel clinical and electrophysiological parameters utilizing the event related potential P300.
    Chinnadurai SA; Venkatesan SA; Shankar G; Samivel B; Ranganathan LN
    Mult Scler Relat Disord; 2016 Nov; 10():1-6. PubMed ID: 27919474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of cerebral lesion volume and lesion distribution on event-related brain potentials in multiple sclerosis.
    Sailer M; Heinze HJ; Tendolkar I; Decker U; Kreye O; v Rolbicki U; Münte TF
    J Neurol; 2001 Dec; 248(12):1049-55. PubMed ID: 12013581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.